[The importance of syndrome X in daily practice].

Abstract

Metabolic syndrome X includes glucose intolerance or type 2 diabetes, dyslipidemia and arterial hypertension which are classical cardiovascular (CV) risk factors. In course of time, other CV risk factors have been added to the syndrome: rheological alterations, endothelial dysfunction, anomalies in the coagulation/fibrinolysis system, microalbuminuria and so on.... Insulin resistance is the cornerstone of metabolic syndrome X, with secondary hyperinsulinism. Upper body obesity is associated with metabolic syndrome X. Simple waist measurements can detect the subjects (10-15% of the population) at increased CV risk with a sensitivity of 70%. This is invaluable for such a simple and cheap test. Diet is the first step in treating these patients and reducing caloric intake is necessary in most of them. Saturated fats will be replaced by polyunsaturated and mono-unsaturated ones. Long-chain carbohydrates with low glycemic index will be suggested. Regular physical activity will be promoted. If these life style modifications fail, drugs can be added: biguanide and glitazone are good candidates. Orlistat has improved metabolic syndrome X on a long-term basis. Drugs that could increase insulin resistance are to be avoided.

• Authors: J C Daubresse
• Journal: Revue medicale de Bruxelles (Rev Med Brux) Vol. 21 Issue 6 Pg. 473-7 (Dec 2000) ISSN: 0035-3639 [Print] Belgium
• Vernacular Title: L'importance du syndrome X dans la pratique quotidienne.
• PMID: 11194491 (Publication Type: Journal Article, Review)

Chemical References

• Hypoglycemic Agents
• Lipoproteins, HDL
• Lipoproteins, LDL
• Thiazoles
• Thiazolidinediones
• Rosiglitazone

Topics

• Anthropometry
• Cardiovascular Diseases (etiology)
• Diet, Reducing
• Exercise
• Humans
• Hyperinsulinism (blood, complications, diagnosis, physiopathology, therapy)
• Hypertension (complications)
• Hypertriglyceridemia (complications)
• Hypoglycemic Agents (therapeutic use)
• Insulin Resistance
• Lipoproteins, HDL (blood)
• Lipoproteins, LDL (blood)
• Obesity (complications)
• Rosiglitazone
• Thiazoles (therapeutic use)
• Thiazolidinediones